Navigation Links
ProSolv Version 4.0.2 Makes Commercial Debut at ASE
Date:5/26/2009

First CVIS Integration with Philips QLAB ultrasound software now available

INDIANAPOLIS, May 26 /PRNewswire/ -- ProSolv CardioVascular, a Fujifilm company (ProSolv), is pleased to announce the commercial availability of Synapse(TM) ProSolv(R) cardiovascular version 4.0.2. Featuring the integration with QLAB advanced quantification software from Philips Healthcare, this latest software release from ProSolv has been designed to enhance clinical workflow, help improve patient care, and reduce the potential for errors by automating the exchange of data between the two systems. The product will be highlighted at the 20th Annual American Society of Echocardiography (ASE) Scientific Sessions to be held June 6-10, 2009, in Washington, DC.

"Our ability to be the first third party to deliver this advanced level of image and information integration with Philips' QLAB is further testament to ProSolv's commitment to our vendor-neutral strategy and to provide uniform clinical workflow throughout an echocardiography department regardless of the source of the information," stated Aaron Waitz, ProSolv President and CEO. "Efficiencies are gained by enabling customers to access proprietary ultrasound data and perform advanced strain rate and 3D analysis at the ProSolv workstation while utilizing the same clinical workflow currently used for routine image review, analysis and reporting with the Synapse ProSolv cardiovascular application," explained Waitz.

Synapse ProSolv cardiovascular version 4.0.2 provides workflow and diagnostic benefits by bringing ready access to the advanced quantification capabilities of QLAB -- including state-of-the-art 2D and 3D ultrasound -- into the echocardiographer's everyday clinical practice. With 4.0.2, users performing image review and reporting can launch the full QLAB application directly from the image in the Synapse ProSolv cardiovascular application for greater efficiency. And more importantly, all exported images from QLAB are converted to DICOM format and then stored with the original study in ProSolv. Clinicians can now review the entire study, including the processed 3D images, throughout the enterprise using ProSolv's Web capability, making this a powerful new combination of tools in the echocardiographer's toolkit.

For more information on Synapse ProSolv cardiovascular 4.0.2 or for a product demonstration, visit ProSolv CardioVascular at booth # 509 at ASE.

About ProSolv CardioVascular, a FUJIFILM Company

Founded in 1989 as Problem Solving Concepts, Inc. (ProSolv) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv CardioVascular's software solutions consist of advanced reporting and image management software, comprehensive support services and integration with third-party clinical applications. The Synapse(TM) ProSolv(R) cardiovascular Enterprise Image and Information Management solution improves physician productivity, enhances customer revenue opportunities, automates complex medical imaging workflow, and maximizes customers' return on investment in capital equipment and clinical information systems. The company is headquartered in Indianapolis, Indiana. For more information visit the ProSolv CardioVascular website at www.prosolv.com.

(C) 2009 ProSolv CardioVascular, a FUJIFILM Company


'/>"/>
SOURCE ProSolv CardioVascular
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ProSolv Releases New Cardiovascular Software
2. ProSolv CardioVascular and GE Healthcare Ultrasound Division Announce Affiliation
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
6. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
7. Retailers Welcome Senate Passage of Mental Health Parity Bill, Urge House to Adopt Senate Version at Subcommittee Markup
8. PreViser Launches New Website and Enhanced Version of Its Oral Disease and Risk Assessment Software
9. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
10. AlphaRx Announces Debt Conversion
11. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... nurses and supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. ... Bundles.” , “Increasingly, supply chain and value analysis professionals have a ‘seat ...
(Date:3/27/2017)... Switzerland (PRWEB) , ... March 27, 2017 , ... ... food industry. Conventional sodium testing methods are complicated and require expert user knowledge. ... a new analytical method dedicated to the simplified, yet highly accurate, determination of ...
(Date:3/27/2017)... ... March 27, 2017 , ... From ... opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) ... (AB) 1512, which proposes a tax on prescription opioids to fund drug rehabilitation ...
(Date:3/25/2017)... (PRWEB) , ... March 25, 2017 , ... Getting earned ... a public relations partner. , All through the year, Garden Media aims to ... releases, working with key influencers and pitching client’s key messages to gain ...
(Date:3/24/2017)... New York, NY (PRWEB) , ... March 24, ... ... cross-platform campaign: “Fighting Infection,” which will spark a conversation on the current obstacles ... decrease the number of completely preventable deaths caused by these infections. , ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . (NASDAQ: ... to address serious pulmonary diseases, today announced that it has ... cystic fibrosis and asthma to its Scientific Advisory Board ... Richard B. Moss , MD, former chief of ... the Cystic Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
(Date:3/27/2017)... , March 27, 2017 ... as the NASDAQ Composite closed the trading session up ... and the S&P 500 was down 0.08%. US markets ... sectors finishing the day in green. Pre-market today, Stock-Callers.com ... Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), ...
Breaking Medicine Technology: